Alkem Laboratories

Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra, India that manufactures and sells pharmaceutical generics, formulations and nutraceuticals in India.

Alkem Laboratories Limited

Type	Public
Traded as	BSE: 539523 NSE: ALKEM
Industry	Pharmaceuticals
Founded	1973
Founder	Samprada Singh
Headquarters	Mumbai, Maharashtra , India
Key people	Basudeo Narayan Singh (Executive Chairman) Sandeep Singh (MD)
Products	Pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health
Revenue	₹84,485 million (US$1.2 billion) (2020)[1]
Operating income	₹12,597 million (US$180 million) (2020)[1]
Net income	₹11,270 million (US$160 million) (2020)[1]
Total assets	₹99,433 million (US$1.4 billion) (2020)[1]
Total equity	₹63,089 million (US$880 million) (2020)[1]
Number of employees	14,000 (2020)[1]
Website	www.alkemlabs.com

Company

Alkem set up its research and development facility for ANDA development at Taloja in 2003. In 2006 anti-infective drug Taxim of Alkem became the first anti-infective drug in the Indian pharmaceutical industry to cross 1,000 million in terms of domestic sales in India. In 2014 Clavam other drug from Alkem crossed 2,000 million mark in terms of domestic sales in India. In 2007 the company filed its first ANDA for drug Amlodipine which was approved in 2009. Alkem has developed a portfolio of 705 branded generic drugs, with 13 of the brands featured among the top 300 brands in India for the fiscal year 2015 and a portfolio of 705 brands in India in the six months ended 30 September 2015. Alkem have 21 manufacturing facilities, 19 in India and 2 in US. 5 of the facilities are US FDA, TGA, UK MHRA approved.

Acquisitions

Alkem has 21 manufacturing facilities: 19 in India and 2 in the US. These 2 facilities in the US were acquired in 2012 and 2013 respectively. In 2014 acquired the "Clindac-A" brand in India from Galderma S.A. In 2015, Alkem acquired a formulation manufacturing facility in the US.

Governance and administration

Samprada Singh was the founder and chairman emeritus of the company, he led and shaped Alkem what it is today, he had a B.Com degree from Patna University. He was the 42nd richest person in India and a billionaire.[2] His brother, Basudeo Narayan Singh,[3] was also the co-founder of the company. Samprada Singh died on 27 July 2019 at the age of 94 years after a brief illness in Mumbai.[4]

Position	Name
Founder Chairman Emeritus	Mr. Samprada Singh
Executive Chairman	Mr.Basudeo Narayan Singh
Joint Managing Director	Mr.Dhananjay Kumar Singh
Joint Managing Director	Mr.Sandeep Singh
Independent Director	Dr.Dheeraj Sharma
Independent Director	Mr.A.K. Purwar
Independent Director	Mr.N. K. Aneja
Independent Director	Mr.R. L. Shenoy
Independent Director	Ms.Sangeeta Singh
Independent Director	Ms.Sudha Ravi

[5]

References

1. "Alkem Laboratories Limited Annual Report 2020" (PDF). Alkem Laboratories Limited. Retrieved 2 July 2020.
2. "Samprada Singh & family". Forbes.
3. "Basudeo Singh". Bloomberg.
4. "Alkem Labs Founder Samprada Singh passes away at the age of 92 years". Medical Dialogues. 27 July 2019.
5. "Board of Directors". Alkem.

External links

• Official website